Literature DB >> 383935

Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.

S E Oberfield, D B Case, L S Levine, R Rapaport, W Rauh, M I New.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 383935     DOI： 10.1016/s0022-3476(79)80787-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Cardiovascular drugs in children: angiotensin-converting enzyme inhibitors.

Authors:  A Schneeweiss
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

Review 2.  Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients.

Authors:  A Schneeweiss
Journal:  Pediatr Cardiol       Date:  1990-10       Impact factor: 1.655

3.  Systemic Hypertension: Management in Children and Adolescents.

Authors:  Craig W. Belsha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-08

4.  Captopril in severe childhood hypertension--reversible anaemia with high dosage.

Authors:  H A Verhaaren; J Vande Walle; A Devloo-Blancquaert
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 5.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

6.  Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril.

Authors:  W Rosendahl; K Hayduk
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

Review 7.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.